Reuben Antony, M.D.
- Associate Professor, Division of Clinical Pediatrics
Philosophy of Care
In the last decade we have gained many new and exciting insights into the mechanistic basis of childhood CNS malignancies. Everyday I aim to provide compassionate and cutting edge care to the children and families who have placed their trust in us.
Dr. Antony offers care to children with tumors of the Central Nervous System and to children with Cancer Predisposition Syndromes.
M.B.B.S., St. Johns Medical College, Bangalore, India 1996
Pediatrics, New York Medical College, New York NY 2006-2008
Pediatric Hematology and Oncology, Children's Hospital of Los Angeles, Los Angeles CA 2008-2011
Pediatric Hematology and Oncology, Great Ormond Street Hospital for Sick Children, London, UK 2001-2003
Pediatric Hematology and Oncology, Hospital for Sick Children, Toronto, Ontario, Canada 2005-2006
American Board of Pediatrics,
American Board of Pediatrics, Pediatric Hematology-Oncology,
Royal College of Physicians (UK) - Pediatrics,
Children�s Oncology Group
Children's Cancer and Leukemia Group (UK)
Royal College of Physicians (UK)
Society of Neuro-Oncology
Honors and Awards
Pediatric Subspecialty Teaching Award Nominee (one of five nominated pediatricians), 2016
Outstanding Pediatric Faculty (Clinical, Academic, Research) nominee (one of five nominated), 2015
Pediatric Subspecialty Teaching Award Nominee (one of five nominated pediatricians), 2015
Best Teacher Award (Dept. of Pediatrics), University of Illinois College of Medicine (UICOMP), 2014
Select Recent Publications
Speckhart BA, Bugaieski E, Antony R, Fernandez KS. Rituximab and intense chemotherapy in a patient with defective cell mediated immunity due to cartilage-hair hypoplasia and Burkitt lymphoma. Pediatr Blood Cancer. 2020;67(7):e28259. doi:10.1002/pbc.28259
Mondal G, Lee JC, Ravindranathan A, et al. Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition. Acta Neuropathol. 2020;139(6):1071-1088. doi:10.1007/s00401-020-02155-5,
Goodarzi A, Garza N, Lechpammer M, Anthony R, Zwienenberg M. The molecular oncology of bilateral high-grade thalamic astrocytomas in children. Childs Nerv Syst. 2019;35(11):2047-2054. doi:10.1007/s00381-019-04372-0.
Fernández KS, Antony R, Kumar A. Patients with "ALPS-like phenotype" diagnosed with immune dysregulation due to LRBA deficiency. Pediatr Blood Cancer. 2019;66(3):e27558. doi:10.1002/pbc.27558.
Kramer M, Antony R, Ozturk A, Lehn K, Graff JP, Chung JH. A Palpable Back Mass as First Presenting Sign of Acute Lymphoblastic Leukemia in a Pediatric Patient. J Pediatr Hematol Oncol. 2019 Jan;41(1):77-78. doi:10.1097/MPH.0000000000001214.
McCarthy LC, Fernandez KS, Antony R. Challenges in the Diagnosis and Management of Pediatric Hemophagocytic Lymphohistiocytosis. Clin Pediatr (Phila). 2018 Aug;57(9):1107-1113. doi:10.1177/0009922817735997.
Gnanamony M, Antony R, Fernández KS, Jaime L, Lin J, Joseph PA, Gondi CS. Chronic radiation exposure of neuroblastoma cells reduces nMYC copy number. Oncol Lett. 2017 Sep;14(3):3363-3370.
Duong C, Yoshida S, Chen C, Barisone G, Diaz E, Li Y, Beckett L, Chung J, Antony R, Nolta J, Nitin N, Satake N. Novel targeted therapy for neuroblastoma: silencing the MXD3 gene using siRNA. Pediatr Res. 2017 Sep;82(3):527-535.
Tanpure S, Boyineini J, Gnanamony M, Antony R, Fernández KS, Libes J, Lin J, Pinson D, Joseph PA, Gondi CS. SPARC overexpression suppresses radiation-induced HSP27 and induces the collapse of mitochondrial Δψ in neuroblastoma cells. Oncol Lett. 2017 Jun;13(6):4602-4610.
Boyineni J, Tanpure S, Gnanamony M, Antony R, Fernández KS, Lin J, Pinson D, Gondi CS. SPARC overexpression combined with radiation retards angiogenesis by suppressing VEGF-A via miR 410 in human neuroblastoma cells. Int J Oncol. 2016 Oct;49(4):1394-406.